The Department of Health is offering a grant to enhance early intervention for psychosis by reducing the duration of untreated psychosis in the United States. With approximately 100,000 adolescents and young adults experiencing a first episode of psychosis annually, the grant aims to support research projects that test practical strategies to shorten the delay between onset of symptoms and initiation of care. By focusing on early identification, rapid referral to evidence-based Coordinated Specialty Care, and effective engagement in services, the grant seeks to preempt functional deterioration and align with the World Health Organization’s recommendation of reducing duration of untreated psychosis to 3 months or less.
Opportunity ID: 314457
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-236 |
| Funding Opportunity Title: | Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 02, 2019 |
| Last Updated Date: | Apr 02, 2019 |
| Original Closing Date for Applications: | May 07, 2022 |
| Current Closing Date for Applications: | May 07, 2022 |
| Archive Date: | Jun 12, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses State governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Private institutions of higher education Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Approximately 100,000 adolescents and young adults in the United States experience a first episode of psychosis (FEP) every year. The early phase of psychotic illness is widely viewed as a critical opportunity for indicated prevention, and a chance to alter the downward trajectory and poor outcomes associated with schizophrenia and related psychotic disorders. Unfortunately, numerous studies find a substantial delay between the onset of psychotic symptoms and the initiation of FEP care; in the U.S. treatment is typically delayed between one and three years. Early identification of FEP, rapid referral to evidence-based Coordinated Specialty Care (CSC) for early psychosis, and effective engagement in CSC services are essential to shortening the duration of untreated psychosis (DUP) and pre-empting the functional deterioration common in psychotic disorders. The World Health Organization advocates reducing DUP to 3 months or less. Accordingly, this Funding Opportunity Announcement (FOA) seeks research project grant applications that test practical, reproducible strategies for substantially reducing DUP among persons with FEP in the U.S. by eliminating bottlenecks or closing gaps in the pathway to CSC services. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-236.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 314457 Full Announcement-PAR-19-236 -> PAR-19-236-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00249617 | May 05, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259343 | May 05, 2019 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269713 | Oct 28, 2021 | May 07, 2022 | View |
Package 1
Mandatory forms
314457 RR_SF424_2_0-2.0.pdf
314457 PHS398_CoverPageSupplement_4_0-4.0.pdf
314457 RR_OtherProjectInfo_1_4-1.4.pdf
314457 PerformanceSite_2_0-2.0.pdf
314457 RR_KeyPersonExpanded_2_0-2.0.pdf
314457 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
314457 RR_Budget_1_4-1.4.pdf
314457 RR_SubawardBudget30_1_4-1.4.pdf
314457 PHS398_ModularBudget_1_2-1.2.pdf
314457 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
314457 RR_SF424_2_0-2.0.pdf
314457 PHS398_CoverPageSupplement_5_0-5.0.pdf
314457 RR_OtherProjectInfo_1_4-1.4.pdf
314457 PerformanceSite_2_0-2.0.pdf
314457 RR_KeyPersonExpanded_2_0-2.0.pdf
314457 PHS398_ResearchPlan_4_0-4.0.pdf
314457 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
314457 RR_Budget_1_4-1.4.pdf
314457 RR_SubawardBudget30_1_4-1.4.pdf
314457 PHS398_ModularBudget_1_2-1.2.pdf
314457 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
314457 RR_SF424_5_0-5.0.pdf
314457 PHS398_CoverPageSupplement_5_0-5.0.pdf
314457 RR_OtherProjectInfo_1_4-1.4.pdf
314457 PerformanceSite_4_0-4.0.pdf
314457 RR_KeyPersonExpanded_4_0-4.0.pdf
314457 PHS398_ResearchPlan_4_0-4.0.pdf
314457 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
314457 RR_Budget_3_0-3.0.pdf
314457 RR_SubawardBudget30_3_0-3.0.pdf
314457 PHS398_ModularBudget_1_2-1.2.pdf
314457 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
